Analysis of cardiovascular-related adverse effects of endostar combined with chemotherapy in 61 NSCLC cases

Chinese Journal of Lung Cancer

Volumn 12, Issue 6, 2009, Pages 577-581

  Meng, Wenjing ^a   Gao, Qi ^a   Wang, Liuchun ^a   Huang, Chun ^a   Li, Kai ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Cardiovascular system adverse effect; Endostar; Logistic regression analysis; Non small cell lung cancer

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; D DIMER; ENDOSTAR; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGE; AGED; BLOOD PRESSURE FLUCTUATION; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE PREDISPOSITION; DIZZINESS; ECG ABNORMALITY; ELECTROCARDIOGRAM; HEADACHE; HEART PALPITATION; HIGH RISK PATIENT; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; RETROSPECTIVE STUDY; SIDE EFFECT; SINUS TACHYCARDIA; ST SEGMENT; SYMPTOMATOLOGY; THROMBOCYTE;

EID: 67650513682     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (8)

1. Yang L, Wang JW, Tang ZM, et a1. phase I clinical trial for recombinant human endostatin. Chin J New Drugs,2004,13(6):548-553.
2. Yang L, Wang J W, Sun Y, et a1.Randomized phase II trial on escalated doses of rh-endostatin(YH-16)for advanced non-small-cell lung cancer. Chin J of Oncol,2006,28(2):138-141
3. Wang JW, Sun Y, Liu YY, et a1. Results of randomized, multicenter, doubleblind phase III trial of rh-endostatin (YH-16)in treatment of advanced non small cell lung cancer patient. Chin J Lung Cancer ,2005,8(4):283-290.
4. Liu YY. Phase III Clinical Trial of Recombinant Human Endostatin in the Treatment for Advanced Non-small Cell Lung Cancer Patients. Bulletin of Chinese Cancer.2005,14(6):398-400.
5. Shi HL, Xu LY, Liu Z, et a1. Phase II clinical trial of homemade human rhendostatin in the treatment of patients with stage III B- IV non-small cell lung cancer. Chin J Lung Cancer,2004,7(4):325-328.
6. Li HB, Peng F. The progress of bevacizumab clinical research. Sichuan Tumor Prevention and Cure.2006,19(1):54.
7. Qin J, Zhang PH, Qian XY, et a1. Analysis of Cardio toxicity of Recombinant Human Endostatin Combined with Chemotherapy. Chinese Journal of Clinical Oncology.2008,35(1):12-14.
8. Yang L, Wang JW, Cui CX, et a1. Rh-endostatin (YH-16) in combination with vinorelbine and cisplatin for advanced non-small-cell lung cancer: a multi-center phase II trial.Chin J New Drugs.2005.14(2): 204-207.